Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
Context: It has been reported that isoprostanes (IPs) have a role in the pathophysiology of ductus arteriosus during the fetal and neonatal period. Our aim in this study was to assess if urinary IPs (uIPs) levels correlate with the risk of developing a hemodynamically significant patent ductus arter...
Saved in:
Main Authors: | Caterina Coviello (Author), Maria Luisa Tataranno (Author), Iuri Corsini (Author), Valentina Leonardi (Author), Mariangela Longini (Author), Francesco Bazzini (Author), Giuseppe Buonocore (Author), Carlo Dani (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isoprostanes as Biomarker for White Matter Injury in Extremely Preterm Infants
by: Caterina Coviello, et al.
Published: (2021) -
Ibuprofen and paracetamol for patent ductus arteriosus
by: Carlo Dani
Published: (2014) -
Oxidative Stress Biomarkers: Establishment of Reference Values for Isoprostanes, AOPP, and NPBI in Cord Blood
by: Mariangela Longini, et al.
Published: (2017) -
Platelet Count and Volume and Pharmacological Closure with Paracetamol of Ductus Arteriosus in Preterm Infants
by: Carlo Dani, et al.
Published: (2022) -
Patent Ductus Arteriosus in Preterm Infants
by: Jia-Yuh Chen
Published: (2012)